Silicon Canals
TRENDING
  • Mobility
  • AI
  • FinTech
  • Software & SaaS
No Result
View All Result
  • Home
  • News
    • COVID-19
    • Startups
    • Scaleups
    • FinTech
    • AI and chatbots
    • Travel & Mobility
    • Software & SaaS
    • Health & Medtech
    • (Crowd)funding
    • Blockchain
    • Internet of things
    • Hardware
    • Accelerators
    • E-commerce
    • Cybersecurity
    • Gaming & Virtual Reality
    • Drones
  • Features
    • Promoted content
    • How-to
    • Knowledge & Insights
    • Guest Contributions
    • Scaling-up in Europe
  • Amsterdampartner
  • Events
  • Newsletter
  • Jobs
  • About
    • Partner with Silicon Canals
    • Team
    • Contact
  • Home
  • News
    • COVID-19
    • Startups
    • Scaleups
    • FinTech
    • AI and chatbots
    • Travel & Mobility
    • Software & SaaS
    • Health & Medtech
    • (Crowd)funding
    • Blockchain
    • Internet of things
    • Hardware
    • Accelerators
    • E-commerce
    • Cybersecurity
    • Gaming & Virtual Reality
    • Drones
  • Features
    • Promoted content
    • How-to
    • Knowledge & Insights
    • Guest Contributions
    • Scaling-up in Europe
  • Amsterdampartner
  • Events
  • Newsletter
  • Jobs
  • About
    • Partner with Silicon Canals
    • Team
    • Contact
No Result
View All Result
Silicon Canals
No Result
View All Result

Dutch biotech startup Toxys that develops animal-free safety tests secures €2M funding

Editorial team by Editorial team
March 16, 2020
in News, (Crowd)funding, Startups
0
Dutch biotech startup Toxys that develops animal-free safety tests secures €2M funding
91
SHARES
LinkedInTwitterWhatsAppFacebook

Toxys is a Dutch biotech startup offering a broad spectrum of innovative in vitro toxicology solutions. Founded in 2014 as a spin-off from Leiden University Medical Center, this company is dedicated to bring relevant information to its clients on potential human health hazards of existing and novel drugs, chemicals and other substances.

Toxys is known for the development of unique animal-free laboratory tests for the safety assessment of novel medicines, cosmetics, chemicals, and food. The biotech company intends to become a global leading supplier of expert in vitro chemical safety testing services.

 - Partner content -
Cost of software - The Software house
The cost of building software
Marek Gajda, CTO of The Software House, shares his insights on building high-quality...Show More
Marek Gajda, CTO of The Software House, shares his insights on building high-quality software. Show Less
Read more

Raises €2M funding

The Dutch biotech company secured €2 million funding from KIKK Capital, Zeeland Investment fund, InnovationQuarter, Toxys management, and Rabobank. The new investment will let Toxys accelerate its growth by expanding its operations in Europe and the US. The company will also broaden its portfolio of in vitro toxicology assays, accelerate international growth and implement its toxicology assays for regulatory applications.

Giel Hendriks, CEO of Toxys, commented: “We have made important progress on development of innovative animal-free tests for drug and chemical safety testing. I am very proud of the strong and dedicated Toxys team to execute our plans to become a trusted expert in toxicological research. With this new investment, we are ready to further expand our business globally and continue to work on the development of novel solutions for toxicological research”.

Patented ToxTracker assay!

Toxys has developed the patented ToxTracker assay that can identify toxic and carcinogenic properties of novel pharmaceuticals, fine chemicals, and agrochemicals at an early stage of product or drug development. It can prevent unnecessary rejections of highly valuable drug products, minimise drug or product development timelines and prevent unwanted animal testing.

The unique capability of ToxTracker is to identify the mode-of-action of toxic compounds that significantly enhance the ability to predict and minimise risks for human health. Currently, it is under review by the international authorities for official acceptance so that the test systems can be included within the standard regulatory safety test strategy.

Besides ToxTracker, Toxys is also prepping to launch the novel ReproTracker test. With this test, it aims to fill a large unmet requirement for an in vitro embryo toxicity test.

Main image picture credits: Toxys

Stay tuned to Silicon Canals for more European technology news.

close

Want to stay on top of the latest rounds, coolest tech and hottest startups?

Subscribe to our free, daily news blast and stay up-to-date!

Check your inbox or spam folder to confirm your subscription.

 - Partner content -
Hiring during COVID Intrinsic Search
Hiring SaaS sales executives
Check out the do's and don'ts while hiring SaaS sales executives
Check out the do's and don'ts while hiring SaaS sales executives Show Less
Read more
Tags: Dutch Startupsfunding
Share3Tweet9SendShare69

Partner content | Work with us

Future of coding: CTOs discuss low-code versus custom code software development for their business

Why now is the perfect time to start hiring for 2021

SaaS sales in 2021: 9 predictions from an industry expert

Diversity in hiring for SaaS: the often overlooked topic of ageism

Boost your scale-up’s growth by outsourcing to these top Eastern European software development companies

Subscribe to our daily newsletter

Check your inbox or spam folder to confirm your subscription.

Breaking news from Amsterdam | Partner

Meet the 10 Dutch scaleups selected by Amsterdam-based Techleap.nl for Rise Programme 2021

Amsterdam-based 3D Hubs acquired by Protolabs for €272.1M; here’s what you need to know

Amsterdam-based INKEF Capital leads €5M Series A funding round of this Dutch startup

4 experts predict what 2021 might hold for the startup ecosystem of Amsterdam

Advertisement

Trending

3D Hubs
Amsterdam

Amsterdam-based 3D Hubs acquired by Protolabs for €272.1M; here’s what you need to know

January 19, 2021
Amsterdam
Amsterdam

9 promising sustainable startups from Amsterdam to watch in 2021

January 20, 2021
BUX
News

The crypto platform of Amsterdam fintech BUX witnesses “explosive growth” as Bitcoin remains popular

January 22, 2021
  • About Silicon Canals
  • Partner with Silicon Canals
  • Contact us
  • Newsletter
  • Disclaimer
  • Privacy policy
  • Terms & Conditions Silicon Canals

Silicon Canals 2014-2020 | Website: Bright Idiots

No Result
View All Result
  • Home
  • News
    • COVID-19
    • Startups
    • Scaleups
    • FinTech
    • AI and chatbots
    • Travel & Mobility
    • Software & SaaS
    • Health & Medtech
    • (Crowd)funding
    • Blockchain
    • Internet of things
    • Hardware
    • Accelerators
    • E-commerce
    • Cybersecurity
    • Gaming & Virtual Reality
    • Drones
  • Features
    • Promoted content
    • How-to
    • Knowledge & Insights
    • Guest Contributions
    • Scaling-up in Europe
  • Amsterdam
  • Events
  • Newsletter
  • Jobs
  • About
    • Partner with Silicon Canals
    • Team
    • Contact

Silicon Canals 2014-2020 | Website: Bright Idiots

X

This website uses cookies to ensure the best possible experience. We may share this information with our advertising and analytics partners. By clicking 'Accept', you agree to our use of cookies and similar technologies. More info